Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

10

Revenue 2017

Lyrica

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lyrica was produced by Pfizer and Eisai.

The good, the bad and the ugly

The good, the bad and the ugly

Pfizer has large sales in CNS - $8.5bn in 2017. The majority come through Lyrica ($5bn). ... In Europe, a patent dispute over Lyrica became arguably the biggest CNS story in recent years.

Pfizer drops neuroscience R&D, cutting 300 jobs

Pfizer drops neuroscience R&D, cutting 300 jobs chronic pain associated with osteoarthritis Lyrica (pregabalin) for fibromyalgia, as well as CNS-targeting drugs in its rare disease programme.

Daiichi drug hits mark in shingles pain, but misses in other indications

Daiichi drug hits mark in shingles pain, but misses in other indications hopes of competing head-to-head with older drug Lyrica (pregabalin) from Pfizer in hard-to-treat neuropathic pain. ... as it remains to be seen whether its benefits in PHN are good enough to persuade prescribers to switch from Lyrica or indeed generic

Ten new medicines recommended in Europe

Ten new medicines recommended in Europe And a generic form of Pfizer's Lyrica from Accord, which will be known as Pregabalin Accord (pregabalin), for the treatment of epilepsy and generalised anxiety disorder, has also gained a

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics